Lutein and Benicar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lutein (lutein) and Benicar (olmesartan medoxomil). Common drug interactions include cough among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Lutein and Benicar. It is created by eHealthMe based on reports of 73 people who take the same drugs from the FDA, and is updated regularly.

What is Lutein?

Lutein has active ingredients of lutein. It is often used in macular degeneration. eHealthMe is studying from 7,461 Lutein users. Check the latest studies of Lutein.

What is Benicar?

Benicar has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 36,002 Benicar users. Check the latest studies of Benicar.



On Jul, 18, 2026

73 people who take Lutein and Benicar together, and have interactions are studied.

Lutein and Benicar drug interactions.

What are the common drug interactions of Lutein and Benicar, by gender? *:

female:

  1. Cough
  2. Gout (uric acid crystals building up in the body)
  3. Infusion site extravasation (flow of (blood or lymph) from infusion site)
  4. Insomnia (sleeplessness)
  5. Nausea (feeling of having an urge to vomit)
  6. Pruritus (severe itching of the skin)
  7. Sudden death
  8. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  9. Eye infection
  10. Feeling hot

male:

  1. Arthralgia (joint pain)
  2. Peripheral swelling
  3. Dyspnoea (difficult or laboured respiration)
  4. Fatigue (feeling of tiredness)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Pleural effusion (water on the lungs)
  7. Pneumonia
  8. Pulmonary oedema (fluid accumulation in the lungs)
  9. Sinusitis (inflammation of sinus)
  10. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)

What are the common drug interactions of Lutein and Benicar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Blood chloride increased
  2. Blood magnesium decreased
  3. Bone disorder
  4. Carbon dioxide decreased
  5. Chronic allograft nephropathy (failure of kidney transplant)
  6. Complications of transplanted kidney
  7. Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
  8. Foot fracture
  9. Gout (uric acid crystals building up in the body)
  10. Haemoglobin decreased

60+:

  1. Asthenia (weakness)
  2. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  3. Sinusitis (inflammation of sinus)
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Blood magnesium decreased
  6. Blood potassium decreased
  7. Cardiomegaly (increased size of heart than normal)
  8. Dyspnoea (difficult or laboured respiration)
  9. Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
  10. Pleural effusion (water on the lungs)

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 9 people, 12.33%
  2. Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 9 people, 12.33%
  3. Pain: 8 people, 10.96%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 9.59%
  5. Diabetes: 7 people, 9.59%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 9.59%
  7. Age-Related Macular Degeneration: 7 people, 9.59%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 6.85%
  9. Depression: 5 people, 6.85%
  10. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 5 people, 6.85%

* Approximation only. Some reports may have incomplete information.

Do you take Lutein and Benicar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lutein and Benicar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lutein:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Benicar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lutein and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Benicar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lutein and olmesartan medoxomil (the active ingredients of Lutein and Benicar, respectively), and Lutein and Benicar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: